BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 15087759)

  • 1. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
    Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
    Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy with nondepleting anti-CD4 monoclonal antibodies but not CD28 antagonists protects islet graft in spontaneously diabetic nod mice from autoimmune destruction and allogeneic and xenogeneic graft rejection.
    Guo Z; Wu T; Kirchhof N; Mital D; Williams JW; Azuma M; Sutherland DE; Hering BJ
    Transplantation; 2001 Jun; 71(11):1656-65. PubMed ID: 11435979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
    Demirci G; Strom TB; Li XC
    J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
    Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L
    Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of skin and islet allograft survival in mice treated with costimulation blockade is mediated by different CD4+ cell subsets and different mechanisms.
    Banuelos SJ; Markees TG; Phillips NE; Appel MC; Cuthbert A; Leif J; Mordes JP; Shultz LD; Rossini AA; Greiner DL
    Transplantation; 2004 Sep; 78(5):660-7. PubMed ID: 15371665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
    Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
    Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
    Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
    Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOD mice have a generalized defect in their response to transplantation tolerance induction.
    Markees TG; Serreze DV; Phillips NE; Sorli CH; Gordon EJ; Shultz LD; Noelle RJ; Woda BA; Greiner DL; Mordes JP; Rossini AA
    Diabetes; 1999 May; 48(5):967-74. PubMed ID: 10331399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of autoimmune but not allogeneic destruction of grafted islets by different therapeutic strategies.
    Kuttler B; Rösing K; Lehmann M; Brock J; Hahn HJ
    J Mol Med (Berl); 1999 Jan; 77(1):226-9. PubMed ID: 9930969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of anti-CD4 with anti-LFA-1 and anti-CD154 monoclonal antibodies promotes long-term survival and function of neonatal porcine islet xenografts in spontaneously diabetic NOD mice.
    Arefanian H; Tredget EB; Rajotte RV; Korbutt GS; Gill RG; Rayat GR
    Cell Transplant; 2007; 16(8):787-98. PubMed ID: 18087999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peri-graft porcine-specific CD4
    Yoon IH; Chung H; Kim HJ; Nam HY; Shin JS; Kim YH; Park CG
    Xenotransplantation; 2019 Sep; 26(5):e12533. PubMed ID: 31111577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum.
    Maki T; Ichikawa T; Blanco R; Porter J
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3434-8. PubMed ID: 1565635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival of segmental pancreas isografts in NOD/Lt mice treated with anti-CD4 and anti-CD8 monoclonal antibodies.
    Mottram PL; Murray-Segal LJ; Han W; Maguire J; Stein-Oakley A; Mandel TE
    Diabetes; 1998 Sep; 47(9):1399-405. PubMed ID: 9726227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice.
    Solomon M; Flodström-Tullberg M; Sarvetnick N
    Transplantation; 2005 May; 79(9):1104-9. PubMed ID: 15880051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of NKG2D mAb on the survival of allogeneic transplanted islets in spontaneous diabetic nonobese diabetic mice].
    Pan H; Lu YR; Zhang ZD; Jin X; Wei LL; Yuan Y; Lu HM; Mai G
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 41(5):836-9, 848. PubMed ID: 21302453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro xenorecognition of adult pig pancreatic islet cells by splenocytes from nonobese diabetic or non-diabetes-prone mice.
    Rivereau AS; You S; Lalain S; Gouin E; Saï P
    Transplantation; 1998 Sep; 66(5):633-8. PubMed ID: 9753345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoreactive effector/memory CD4+ and CD8+ T cells infiltrating grafted and endogenous islets in diabetic NOD mice exhibit similar T cell receptor usage.
    Diz R; Garland A; Vincent BG; Johnson MC; Spidale N; Wang B; Tisch R
    PLoS One; 2012; 7(12):e52054. PubMed ID: 23251685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
    Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
    Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.